Literature DB >> 19808991

A case of secondary dystonia responding to levodopa.

Geneviève Bernard1, Michel Vanasse, Sylvain Chouinard.   

Abstract

The authors report a patient with dystonia secondary to bilateral lesions of the basal ganglia, who improved dramatically with levodopa. The patient presented at the age of 4 years with progressive dystonia of the lower extremities and right upper extremity. Magnetic resonance imaging (MRI) of the brain showed bilateral hyperintensities of the globus pallidus that remained stable over the years. Despite extensive investigations, the etiology of her basal ganglia lesions remained nebulous. The patient's dystonia responded to Trihexyphenidyl and to tetrabenazine, but these medications needed to be stopped because of side effects. At the age of 12 years, small doses of levodopa-carbidopa were tried and resulted in dramatic improvement of her dystonia. The authors believe that in the pediatric population with secondary dystonias other than Segawa disease, even though this has been reported only rarely to be effective, a therapeutic trial with levodopa should be considered in some instances.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19808991     DOI: 10.1177/0883073809346847

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  6 in total

Review 1.  Treatment of dystonia.

Authors:  Mary Ann Thenganatt; Joseph Jankovic
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 2.  Dystonia and leveraging oral pharmacotherapy.

Authors:  Michelle Ann C Sy; Hubert H Fernandez
Journal:  J Neural Transm (Vienna)       Date:  2021-04-20       Impact factor: 3.575

3.  Treatment of generalized dystonia.

Authors:  Naomi Lubarr; Susan Bressman
Journal:  Curr Treat Options Neurol       Date:  2011-06       Impact factor: 3.598

4.  Childhood dystonias.

Authors:  Samer D Tabbal
Journal:  Curr Treat Options Neurol       Date:  2015-03       Impact factor: 3.598

Review 5.  Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation.

Authors:  Ian O Bledsoe; Aaron C Viser; Marta San Luciano
Journal:  Neurotherapeutics       Date:  2020-10-23       Impact factor: 7.620

Review 6.  Clinical Management of Dystonia in Childhood.

Authors:  Quyen N Luc; Jyes Querubin
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.930

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.